The significant drop in OSR Holdings, Inc. (OSRH) share price from approximately $11 to below $3 in February 2025 appears to be primarily linked to the completion of its de-SPAC transaction and subsequent market dynamics.
Here's a breakdown of the short-term factors:
- Business Combination Completion: OSR Holdings, Inc., formerly Bellevue Life Sciences Acquisition Corp. (BLAC), completed its business combination with OSR Holdings Co., Ltd. on February 14, 2025. The combined entity commenced trading on the Nasdaq Stock Market LLC under the ticker "OSRH" on February 18, 2025.1 This transition from a SPAC to an operating company often introduces volatility as the market re-evaluates the new entity's fundamentals and liquidity.
- Company's Own Assessment of "Short-Term Dynamics": An August 2025 filing (EX99.1) from OSR Holdings directly addressed this price movement, stating that "During the final deSPAC process, from February 10th to 14th, a series of steep share price declines occurred from ~$11 to below $3 for no known fundamental reasons but only upon 'short - term dynamics' while volumes were still thin as a SPAC." The company further suggested that this was an "excessive and short sale - driven share price decline" that was likely to be corrected by underlying market fundamentals.2 This indicates the company itself perceived the drop as driven by market mechanics and short-selling pressure rather than new adverse fundamental news.
- Equity Line of Credit (ELOC): In February 2025, OSR Holdings entered into an equity line of credit agreement, providing access to up to $80 million in capital.3 While a source of funding, ELOCs can be viewed negatively by the market as they represent potential future dilution, which can put downward pressure on share prices, especially if the company begins drawing on the facility.
- SPAC Redemptions: In connection with the special meeting to approve the business combination, 57,821 shares of BLAC Common Stock were tendered for redemption.4 High redemption rates in a SPAC can reduce the cash proceeds available to the combined company and impact market sentiment, as it signals a lack of confidence from a portion of the SPAC's original investors.
The combination of the de-SPAC transition, potential short-selling activity, and the announcement of a dilutive financing mechanism likely contributed to the rapid price decline in February 2025. Fintel's institutional ownership data shows OSRH's share price at $3.11 on February 18, 2025, further confirming the timing of the drop following the Nasdaq listing.5
